Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription.

Molecular and Cellular Biology
Kevin A WalterJ Laterra

Abstract

Scatter factor/hepatocyte growth factor (SF/HGF) expression has been linked to malignant progression in glial neoplasms. Using two glioma cell lines, U373MG and SNB-19, we have demonstrated that SF/HGF stimulation allows cells to escape G(1)/G(0) arrest induced by contact inhibition or serum withdrawal. SF/HGF induced effects on two mechanisms of cell cycle regulation: suppression of the cyclin-dependent kinase inhibitor p27 and induction of the transcription factor c-Myc. Regulation of p27 by SF/HGF was posttranslational and is associated with p27 nuclear export. Transient transfections of U373MG and SNB-19 with wild-type p27 and a degradation-resistant p27T187A mutant were insufficient to induce cell cycle arrest, and SF/HGF downregulation of p27 was not necessary for cell cycle reentry. Analysis of Cdk2 kinase activity and p27 binding to cyclin E complexes in the presence of exogenous wild-type p27 or p27T187A demonstrated that Cdk2 activity was not necessary for SF/HGF-mediated G(1)/S transition. Similarly, overexpression of dominant-negative forms of Cdk2 did not block SF/HGF-triggered cell cycle progression. In contrast, SF/HGF transcriptionally upregulated c-Myc, and overexpression of c-Myc was able to prevent G(1)/G(0) ...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Sep 30, 1991·International Journal of Cancer. Journal International Du Cancer·M PratP M Comoglio
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M ParkG Vande Woude
Jun 1, 1995·The Journal of Cell Biology·R Zarnegar, G K Michalopoulos
Dec 1, 1994·The Journal of Cell Biology·E M RosenI D Goldberg
Mar 1, 1994·Molecular and Cellular Biology·H MatsushimeJ Y Kato
Dec 24, 1993·Science·S van den Heuvel, E Harlow
Mar 1, 1993·American Journal of Respiratory Cell and Molecular Biology·K M WeidnerW Birchmeier
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·W R SellersW G Kaelin
Jun 15, 1996·Experimental Cell Research·G G Skouteris, C H Schröder
Jul 17, 1996·International Journal of Cancer. Journal International Du Cancer·E M RosenI D Goldberg
Jan 1, 1997·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J Y LjubimovaA A Demetriou
Jun 1, 1997·Genes & Development·R J SheaffB E Clurman
Jun 27, 1997·Biochemical and Biophysical Research Communications·J LaterraP Johnston
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·F B FurnariW K Cavenee
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C HeB Vogelstein
Mar 4, 1999·Neurologia Medico-chirurgica·Y HiroseT Kawase
Mar 17, 1999·Molecular Cell·R SearsJ R Nevins
Jul 20, 1999·Journal of Neuropathology and Experimental Neurology·R PivaD Schiffer
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·H HermekingK W Kinzler
Mar 29, 2000·Journal of Neurochemistry·T FuseK Yamada
Apr 25, 2000·Molecular and Cellular Biology·E Santoni-RugiuJ Lukas

❮ Previous
Next ❯

Citations

Feb 1, 2008·Molecular Cancer Research : MCR·Thomas E ReznikJohn Laterra
Oct 11, 2005·Neuro-oncology·Roger Abounader, John Laterra
Jul 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Chong-Feng GaoGeorge F Vande Woude
Dec 2, 2014·Neurosurgical Focus·Ahmed J AwadRoger Abounader
Aug 12, 2008·Biochimica Et Biophysica Acta·Megumi IiizumiKounosuke Watabe
Dec 17, 2016·Cancer Biomarkers : Section a of Disease Markers·Flávia S DonairesElza T Sakamoto-Hojo
Jul 12, 2017·Cancers·Nichola CruickshanksRoger Abounader
May 4, 2004·Annals of Neurology·Mir Ahamed HossainJohn Laterra
Feb 26, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Min Kyung Cho, Sang Geon Kim
Nov 1, 2008·Cancer·Doo-Sik KongDo-Hyun Nam
May 22, 2013·Growth Factors·Panagiotis J VlachostergiosChristos N Papandreou
Oct 22, 2017·The Journal of Pharmacology and Experimental Therapeutics·Anita ThyagarajanRavi Prakash Sahu
Sep 29, 2011·American Journal of Reproductive Immunology : AJRI·Ehsan SoleymaninejadianEsmaeil Samadian
Oct 18, 2020·International Journal of Molecular Sciences·Elizabeth Qian Xu MulcahyRoger Abounader
Apr 19, 2013·Molecular Cancer Research : MCR·Kazuyuki MatsushitaFumio Nomura
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bachchu LalJohn Laterra
Dec 21, 2004·Critical Reviews in Oncology/hematology·Wen G JiangToshikazu Nakamura
Oct 19, 2020·Current Cancer Drug Targets·Milad AshrafizadehManoj Garg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.